PHC Holdings Corp. (JP:6523)

:6523

6523

PHC Holdings Corp.

RESEARCH TOOLSreports

Want to see JP:6523 full AI Analyst Report?

PHC Holdings Corp. (6523) Price & Analysis

1 Followers

6523 Stock Chart & Stats

¥1112.00

¥4.00(0.41%)

At close: Jan 08 4:00 PM EST

¥1112.00

¥4.00(0.41%)

Day’s Range― - ―

52-Week Range¥856.00 - ¥1,189.00

Previous CloseN/A

Volume174.10K

Average Volume (3M)164.09K

Market Cap

¥135.72B

Enterprise Value¥334.53B

Total Cash (Recent Filing)¥39.82B

Total Debt (Recent Filing)¥234.56B

Price to Earnings (P/E)277.7

Beta0.54

Next Earnings

Aug 06, 2026

EPS Estimate

29.04

Next Dividend Ex-DateN/A

Dividend Yield3.73%

Share Statistics

EPS (TTM)3.85

Shares Outstanding126,727,356

10 Day Avg. Volume194,380

30 Day Avg. Volume164,093

Financial Highlights & Ratios

PEG Ratio-2.94

Price to Book (P/B)0.85

Price to Sales (P/S)0.38

P/FCF Ratio4.13

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)122.74

Revenue Forecast (FY)¥367.30B

Bulls Say, Bears Say

Bulls Say

Recurring ConsumablesPHC's business mix includes diagnostic instruments plus consumables and service, creating recurring revenue from installed bases. This durable annuity-like stream cushions capital-equipment cyclicality, supports predictability of sales and margins, and underpins long-term cash generation.

Revenue Growth & MarginsThe company shows a sustained improvement in top-line growth (latest year +12.9%) while maintaining mid‑40% gross margins. That combination signals structural pricing power and demand resilience across diagnostics and life‑science equipment, supporting margin sustainability over multiple quarters.

Consistent Cash GenerationOperating cash flow has been positive and free cash flow remained positive even in loss years, indicating solid cash conversion from operations. This consistent cash generation enhances financing flexibility for R&D, capex and debt servicing, reducing dependence on external capital over time.

Bears Say

Elevated LeverageAlthough leverage has improved from prior years, debt-to-equity around 1.45x still represents meaningful financial exposure. Elevated leverage limits strategic optionality, increases interest burden sensitivity, and raises refinancing and covenant risks if cashflows weaken over the medium term.

Earnings VolatilityPHC's earnings have been highly cyclical: multi-year losses followed by a profit spike and then near break-even. This volatility complicates forecasting, weakens return metrics and suggests profits may be sensitive to single-year factors, undermining confidence in the durability of recent recovery.

Debt Coverage RiskOperating cash flow, while positive, covers only a low‑to‑mid 20% portion of total debt, implying limited immediate headroom. Continued reliance on sustained cash generation or refinancing elevates medium-term liquidity risk, especially if revenue or margins deteriorate.

PHC Holdings Corp. News

Is 2GY a Buy, Before Earnings?

PHC Holdings Corp. (2GY) is scheduled to report 4th quarter earnings on 05/13/2026. Regarding Q4 estimates, Wall Street...

1M ago

2GY Upcoming Earnings Report: What to Expect?

PHC Holdings Corp. (2GY) is scheduled to report 2nd quarter earnings on 11/12/2025. Regarding Q2 estimates, Wall Street...

7M ago

6523 FAQ

What was PHC Holdings Corp.’s price range in the past 12 months?

PHC Holdings Corp. lowest stock price was ¥856.00 and its highest was ¥1189.00 in the past 12 months.

What is PHC Holdings Corp.’s market cap?

PHC Holdings Corp.’s market cap is ¥135.72B.

When is PHC Holdings Corp.’s upcoming earnings report date?

PHC Holdings Corp.’s upcoming earnings report date is Aug 06, 2026 which is in 55 days.

How were PHC Holdings Corp.’s earnings last quarter?

PHC Holdings Corp. released its earnings results on May 13, 2026. The company reported -¥1.6 earnings per share for the quarter, missing the consensus estimate of ¥15.83 by -¥17.43.

Is PHC Holdings Corp. overvalued?

According to Wall Street analysts PHC Holdings Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does PHC Holdings Corp. pay dividends?

PHC Holdings Corp. pays a Semiannually dividend of ¥21 which represents an annual dividend yield of 3.73%. See more information on PHC Holdings Corp. dividends here

What is PHC Holdings Corp.’s EPS estimate?

PHC Holdings Corp.’s EPS estimate is 29.04.

How many shares outstanding does PHC Holdings Corp. have?

PHC Holdings Corp. has 126,727,356 shares outstanding.

What happened to PHC Holdings Corp.’s price movement after its last earnings report?

PHC Holdings Corp. reported an EPS of -¥1.6 in its last earnings report, missing expectations of ¥15.83. Following the earnings report the stock price went down -1.957%.

Which hedge fund is a major shareholder of PHC Holdings Corp.?

Currently, no hedge funds are holding shares in JP:6523

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

PHC Holdings Corp.

PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.